| 前收市價 | 0.3600 |
| 開市 | 0.8000 |
| 買盤 | 0.7000 |
| 賣出價 | 0.9000 |
| 拍板 | 4.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 0.8000 - 0.8000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 116 |
ZacksBiogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Biogen's (BIIB) Qalsody is the first therapy approved to treat a rare genetic form of ALS in Europe
ZacksJ&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
Data from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study endpoints in depression patients with insomnia symptoms.
ZacksMerck (MRK) to Buy Private Ophthalmology Company EyeBio
Merck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a novel Wnt agonist antibody being developed for treating retinal diseases.
